Relevant Facts from Aerosol Measles Vaccine Studies

F. Jorge, M. Garcia-Garcia, J. Díaz-Ortega, Deyanira Castaneda
{"title":"Relevant Facts from Aerosol Measles Vaccine Studies","authors":"F. Jorge, M. Garcia-Garcia, J. Díaz-Ortega, Deyanira Castaneda","doi":"10.4236/WJV.2016.63006","DOIUrl":null,"url":null,"abstract":"Most of the facts regarding measles aerosol vaccination have been quite thoroughly dealt with in the book by S. Plotkin, Mass Vaccination: Global Aspects—Progress and Obstacles (2006 Ed) [1]. However, there are some aspects mentioned there that should perhaps have been emphasized more strongly and others that have emerged as relevant issues since then. We shall start with the quite important point that in the Sabin et al. [2] first study made in Monterrey, N. L., Mexico [3], antibody reaction for recipients of respiratory-route Edmonston-Zagreb vaccines was not fully developed (100%) until six months after aerosol inhalation. At six weeks, only 90% had increased blood levels of antibody, a fact for which there is no easy explanation, but one which should be considered when dealing with serologic evaluation of measles vaccines given by aerosol in which shortterm results less than encouraging. Results of the second study performed by Sabin et al. in Monterrey [2] establish that the percentage of sero-responses is directly dose-dependent. In turn, the dose itself depends on at least three facts: 1) concentration of virus in the vaccine used; 2) kind of nebulizer used; and 3) time of exposure. Another point to be stressed is that the vaccine used in the first trials [1]-[3], as well in the aerosol mass vaccination in Mexico, though originally the Ickic strain attenuated in HDP, was also grown for final harvesting in HDP (MRC-5), whereas current Edmonston-Zagreb vaccines are obtained by final culture in chick embryo fibroblasts that provide 1 log more final product, more beneficial from an economic point of view, but not for adaptation to human tissues. A crucial consideration in aerosol measles mass campaigns is the lack of electricity/ energy supply, particularly in rural communities. To deal with these issues, a rudimentary assembly was utilized to produce the aerosol for mass vaccinations performed during the serious Mexican epidemic of 1990-1991: a tire pump connected to a Clay-Adams nebulizer. As this equipment works only with direct current, a car battery was used to supply sufficient energy to vaccinate thousands of children.","PeriodicalId":57190,"journal":{"name":"疫苗(英文)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"疫苗(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/WJV.2016.63006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Most of the facts regarding measles aerosol vaccination have been quite thoroughly dealt with in the book by S. Plotkin, Mass Vaccination: Global Aspects—Progress and Obstacles (2006 Ed) [1]. However, there are some aspects mentioned there that should perhaps have been emphasized more strongly and others that have emerged as relevant issues since then. We shall start with the quite important point that in the Sabin et al. [2] first study made in Monterrey, N. L., Mexico [3], antibody reaction for recipients of respiratory-route Edmonston-Zagreb vaccines was not fully developed (100%) until six months after aerosol inhalation. At six weeks, only 90% had increased blood levels of antibody, a fact for which there is no easy explanation, but one which should be considered when dealing with serologic evaluation of measles vaccines given by aerosol in which shortterm results less than encouraging. Results of the second study performed by Sabin et al. in Monterrey [2] establish that the percentage of sero-responses is directly dose-dependent. In turn, the dose itself depends on at least three facts: 1) concentration of virus in the vaccine used; 2) kind of nebulizer used; and 3) time of exposure. Another point to be stressed is that the vaccine used in the first trials [1]-[3], as well in the aerosol mass vaccination in Mexico, though originally the Ickic strain attenuated in HDP, was also grown for final harvesting in HDP (MRC-5), whereas current Edmonston-Zagreb vaccines are obtained by final culture in chick embryo fibroblasts that provide 1 log more final product, more beneficial from an economic point of view, but not for adaptation to human tissues. A crucial consideration in aerosol measles mass campaigns is the lack of electricity/ energy supply, particularly in rural communities. To deal with these issues, a rudimentary assembly was utilized to produce the aerosol for mass vaccinations performed during the serious Mexican epidemic of 1990-1991: a tire pump connected to a Clay-Adams nebulizer. As this equipment works only with direct current, a car battery was used to supply sufficient energy to vaccinate thousands of children.
气溶胶麻疹疫苗研究的相关事实
关于麻疹气溶胶疫苗接种的大多数事实已经在S. Plotkin的书中得到了相当彻底的处理,大规模疫苗接种:全球方面-进展和障碍(2006年版)b[1]。然而,其中提到的一些方面也许应该得到更有力的强调,而其他方面自那时以来已成为相关问题。我们将从非常重要的一点开始,在Sabin等人在墨西哥n.l L州蒙特雷进行的第一项研究中,直到吸入气溶胶6个月后,呼吸道途径的Edmonston-Zagreb疫苗的接受者的抗体反应才完全发展(100%)。在6周时,只有90%的人血液抗体水平升高,这一事实不容易解释,但在处理气雾剂接种的麻疹疫苗的血清学评估时应考虑到这一点,因为气雾剂接种的短期结果不太令人鼓舞。Sabin等人在蒙特雷进行的第二项研究的结果证实,血清反应的百分比与剂量直接相关。反过来,剂量本身取决于至少三个事实:1)所用疫苗中的病毒浓度;2)使用的雾化器种类;3)曝光时间。另一点需要强调的是,在第一次试验中使用的疫苗[1]-[3],以及在墨西哥进行的气溶胶大规模疫苗接种,虽然最初在HDP中减弱了Ickic菌株,但也在HDP (MRC-5)中进行了最终收获,而目前的Edmonston-Zagreb疫苗是通过在鸡胚成纤维细胞中进行最终培养获得的,从经济角度来看,这种疫苗提供了1 log的最终产品,但不适合人体组织。气溶胶麻疹大规模运动的一个关键考虑因素是缺乏电力/能源供应,特别是在农村社区。为了解决这些问题,在1990-1991年墨西哥严重流行病期间,使用了一个基本组件来生产用于大规模接种疫苗的气雾剂:一个轮胎泵连接到Clay-Adams喷雾器。由于该设备只能使用直流电,因此使用汽车电池提供足够的能量为数千名儿童接种疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
95
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信